Diabetic atrial fibrillation patients: mortality and risk for stroke or embolism during a 10‐year follow‐up

Abstract

Diabetic patients with atrial fibrillation frequently have additional risk factors for stroke or embolism, and thus should be treated with oral anticoagulation. Whether in the rare cases of atrial fibrillation, in whom diabetes is the only clinical risk factor, oral anticoagulation is indicated cannot be answered by the present study.

Influences of Autonomic Nervous System on Atrial Arrhythmogenic Substrates and the Incidence of Atrial Fibrillation in Diabetic Heart

“…3,4) In epidemiological studies, DM is associated with an increased incidence of AF. [5][6][7][8] Because DM and AF both independently increase major serious clinical conditions such as stroke and the presence of both compounds the risk, 9,10) the understanding of this pathophysiological linkage would be essential in developing a therapeutic strategy for risk reduction. However, exactly how DM facilitates AF remains unclear.…”

Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation

“…There were 44 diagnostic accuracy studies and five prognostic studies [106][107][108][109][110] accepted into the review.…”

“…All five prognostic accuracy studies included [106][107][108][109][110] had a population of non-valvular/non-rheumatic AF. Of the categories of pathologies sought, only heart failure and valvular heart disease were represented.…”

“…Of the categories of pathologies sought, only heart failure and valvular heart disease were represented. Three of the studies were prospective studies 106,107,110 with follow-up ranging from mean 1.3 to 9.6 years. Two of the studies 108,109 were retrospective.…”

Catheter radiofrequency ablation in atrial fibrillation and flutter management in patients with comorbidities

“…Апноэ во время сна предрасполагает к изменению состояния веге-тативной системы или увеличению размера предсердий и [6] представлены отдельные варианты противорецидивного лечения арит-мии у пациентов с АГ, ИБС, ХСН. При этом алгоритма для пациентов с СД не создано, хотя данная патология встречается у 10-25% больных с ФП [7,8].…”